Enhanced Absorption of Nasulin™, an Ultrarapid-Acting Intranasal Insulin Formulation, Using Single Nostril Administration in Normal Subjects
Journal of diabetes science and technology - United States
doi 10.1177/193229681100500116
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2011
Authors
Publisher
SAGE Publications